HCB101, a novel Fc-based anti-SIRPα-CD47 fusion protein, has received orphan drug designation (ODD) from the FDA for the ...

A feature of pancreatic cancer cells' surroundings determines whether they grow fast or become resistant to chemotherapy, a ...

As theranostic radiopharmaceuticals gain prevalence, companies must overcome associated regulatory, manufacturing and ...

She identified 2 primary frontiers for clinical investigation: the eradication of persistent cancer cells and the management ...

A cohort study examines whether the use of common medications was associated with worse outcomes in patients with lung cancer taking immunotherapy.

Cancer, the second leading cause of death worldwide, is being targeted by a team of local researchers collaborating to extend ...

Patients with stage 4 lung cancer and EGFR mutations may benefit from combination therapies that improve disease control. The American Society of Clinical Oncology (ASCO) released updated treatment ...

Docetaxel rechallenge significantly improved survival compared with cabazitaxel in certain men with metastatic ...

Chilean chocolate with grape residue slows down bacteria associated with gastric cancer, according to a recent scientific study.

Chemotherapy causes harsh side effects because it targets fast-growing cancer cells along with healthy cells like hair follicles, gut lining, and bone marrow. This leads to fatigue, nausea, hair loss, ...

New research exposes the molecular switches that let some cancers shapeshift and reveals how they might finally be stopped. Certain cancers are extremely difficult to treat, and carcinomas are among ...

HER2-positive gastric cancer accounts for a substantial proportion of advanced cases and has long been treated with HER2-targeted therapies. While trastuzumab deruxtecan has shown superior activity ...